What the Law and Bioethics Tell Us About Synthetic Human Embryos
By Barbara Pfeffer Billauer,
Bill of Health
| 10. 13. 2023
A synthetic embryo can now be constructed from very early pre-embryonic cells – without the need for an egg or sperm. These were initially created in mice. In April, researchers in China published about their creation of synthetic monkey embryos. In June, it was reported that the first synthetic human models were apparently created. This development throws a moral monkey-wrench into the current moratoria on embryonic research after 14 days. But there are more problems ahead.
Two weeks – the 14-day Rule
Of immediate concern are the ramifications of the 14-day rule, which imposes a (voluntary in the U.S.) moratorium on experimentation on human embryos older than 14 days; after that, they must be terminated. Strictly speaking, at this point, the fertilized egg (zygote) is called by various names, e.g., blastocyst and a “morula” (“little cherry”) because depending on the stage of development, that’s what the entity resembles. This zygote does not achieve full “embryo” status until day 14 after fertilization, the beginning of “gastrulation.”
In biological terms, the 15th day of embryo development is the point when...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...